These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 16682612)

  • 1. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events.
    Healy AM; Pickard MD; Pradhan AD; Wang Y; Chen Z; Croce K; Sakuma M; Shi C; Zago AC; Garasic J; Damokosh AI; Dowie TL; Poisson L; Lillie J; Libby P; Ridker PM; Simon DI
    Circulation; 2006 May; 113(19):2278-84. PubMed ID: 16682612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
    Czyz A; Kołacz E; Angerer D; Zawilska K
    Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter by Krishnan et al regarding article, "Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events".
    Krishnan U; Goodall AH; Bugert P
    Circulation; 2007 Feb; 115(6):e186; author reply e187. PubMed ID: 17296864
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study.
    Walter MF; Jacob RF; Jeffers B; Ghadanfar MM; Preston GM; Buch J; Mason RP;
    J Am Coll Cardiol; 2004 Nov; 44(10):1996-2002. PubMed ID: 15542282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
    van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immature platelets in patients with acute coronary syndromes.
    Grove EL; Hvas AM; Kristensen SD
    Thromb Haemost; 2009 Jan; 101(1):151-6. PubMed ID: 19132202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI).
    Lund J; Qin QP; Ilva T; Nikus K; Eskola M; Porela P; Kokkala S; Pulkki K; Pettersson K; Voipio-Pulkki LM
    Ann Med; 2006; 38(3):221-8. PubMed ID: 16720436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
    Boekholdt SM; Peters RJ; Hack CE; Day NE; Luben R; Bingham SA; Wareham NJ; Reitsma PH; Khaw KT
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1503-8. PubMed ID: 15178568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction.
    Saraf S; Christopoulos C; Salha IB; Stott DJ; Gorog DA
    J Am Coll Cardiol; 2010 May; 55(19):2107-15. PubMed ID: 20447533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.
    Canale ML; Stroppa S; Caravelli P; Petronio AS; Mariotti R; Mariani M; Balbarini A; Barsotti A
    Coron Artery Dis; 2006 Dec; 17(8):693-8. PubMed ID: 17119378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging.
    Jahnke C; Nagel E; Gebker R; Kokocinski T; Kelle S; Manka R; Fleck E; Paetsch I
    Circulation; 2007 Apr; 115(13):1769-76. PubMed ID: 17353441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma CD93 concentration is a potential novel biomarker for coronary artery disease.
    Mälarstig A; Silveira A; Wågsäter D; Öhrvik J; Bäcklund A; Samnegård A; Khademi M; Hellenius ML; Leander K; Olsson T; Uhlén M; de Faire U; Eriksson P; Hamsten A
    J Intern Med; 2011 Sep; 270(3):229-36. PubMed ID: 21332844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
    Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.
    Huang SS; Huang PH; Chen YH; Sung SH; Chiang KH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 Dec; 19(8):597-602. PubMed ID: 18971786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.